Fig. 2
![Fig. 2](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12913-017-2188-1/MediaObjects/12913_2017_2188_Fig2_HTML.gif)
Unadjusted treatment outcomes for the overall cohort and stratified per treatment regimen. # Fifteen patients discontinued treatment prematurely but achieved an SVR24; eleven patients treated with TPV/PR and four patients treated with BOC/PR. These patients were counted in both the discontinuation rate and the SVR rate